News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
BioSpace News Archive
Browse BioSpace’s published news and press releases by year, month, and day.
168 Results
Year
2005 (24679)
2006 (34770)
2007 (39687)
2008 (39410)
2009 (42118)
2010 (39616)
2011 (38383)
2012 (38416)
2013 (36268)
2014 (39672)
2015 (44432)
2016 (38329)
2017 (37188)
2018 (39119)
2019 (51334)
2020 (57663)
2021 (58720)
2022 (53928)
2023 (42564)
2024 (37441)
2025 (33090)
2026 (19287)
Month
January (2882)
February (2030)
March (1769)
April (2200)
May (2664)
June (3161)
July (3087)
August (3800)
September (4259)
October (5135)
November (4629)
December (3503)
Day
1 (168)
2 (76)
4 (3)
5 (150)
6 (144)
7 (139)
8 (146)
9 (72)
10 (4)
11 (1)
12 (157)
13 (167)
14 (125)
15 (111)
16 (54)
17 (4)
19 (20)
20 (49)
21 (57)
22 (62)
23 (38)
25 (1)
26 (79)
27 (106)
28 (97)
Year
2005
2006
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
2026
Month
January
February
March
April
May
June
July
August
September
October
November
December
Day
1
2
4
5
6
7
8
9
10
11
12
13
14
15
16
17
19
20
21
22
23
25
26
27
28
Pharm Country
Mylan Expands Access to HIV/AIDS Medicines with Launch of First Generic Sustiva Tablets
Mylan today announced the U.S. launch of Efavirenz Tablets USP, 600 mg, the first generic version of Bristol-Myers Squibb’s Sustiva
February 1, 2018
·
5 min read
Drug Development
Panacea Pharma Completes Enrollment in Phase I Study of First-in-Class Cancer Vaccine Therapy in Patients with Persistent Prostate Cancer
PAN-301-1 is a novel nanoparticle immunotherapy vaccine candidate targeting HAAH also known as ASPH.
February 1, 2018
·
6 min read
Pharm Country
Getinge USA Sales, LLC, Launches Maquet Moduevo Ceiling Supply Unit Product Line in United States
Getinge, a leading global provider of innovative medical technology, today announced the U.S. launch of its Maquet Moduevo ceiling supply unit product line.
February 1, 2018
·
3 min read
Biotech Bay
Strategikon Advances Planning and Financial Management for Life Sciences With Launch of Clinical Maestro
Strategikon Pharma today announced the release of the Sponsor Edition of the Clinical Maestro platform.
February 1, 2018
·
2 min read
Business
TraceLink Expands Leadership Team With New Senior VP of Engineering and New CTO Appointment
TraceLink today announced two key new senior leadership appointments.
February 1, 2018
·
5 min read
BioMidwest
GTCR and Regatta Medical Announce Strategic Investment in Resonetics
Going forward, the existing Resonetics management team, led by CEO Tom Burns, will continue in their existing roles as a subsidiary of Regatta Medical.
February 1, 2018
·
4 min read
Business
Aytu BioScience to Report Fiscal Second Quarter 2018 Results and Business Update
The Company will review recent accomplishments and provide an overview of its business and growth strategy.
February 1, 2018
·
4 min read
Business
Avecia Announces Opening of Cambridge, MA Office
Avecia announced today the opening of a new corporate office in Cambridge, MA, to support its operations and corporate development activities, and to be more accessible to clients.
February 1, 2018
·
1 min read
Business
Charles River Laboratories Makes Investments in High-Throughput Screening Infrastructure
Charles River Laboratories today announced a new agreement which grants Charles River commercial access to AstraZeneca’s (NYSE: AZN) high-throughput screening (HTS) and compound management infrastructure.
February 1, 2018
·
3 min read
BioMidwest
Eccrine Systems Awarded USAF Contract for Monitoring Cognitive Status Using Sweat
Eccrine Systems, has been awarded a $750,000 SBIR Phase II contract by the United States Air Force, focused on real-time measurement of specific biomarkers in human sweat as an index of cognitive performance.
February 1, 2018
·
2 min read
Previous
4 of 17
Next